Status:

COMPLETED

Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test

Lead Sponsor:

MedMira Laboratories Inc.

Conditions:

HIV Infections

Eligibility:

All Genders

13+ years

Phase:

NA

Brief Summary

To determine the efficacy of an improved rapid diagnostic test using venous whole blood and fingerstick whole blood. The clinical performance of Reveal G4 Rapid HIV-1 Antibody Test will be determined ...

Detailed Description

This clinical trial is a multi-center study to assess the performance characteristics of a rapid in vitro diagnostic assay, the Reveal G4 Rapid HIV-1 Antibody Test (Reveal G4). Specifically, the objec...

Eligibility Criteria

Inclusion

  • All subjects must be at least 18 years of age, able to sign consent form, complete the risk assessment questionnaire, and provide the required blood samples: fingerstick sample (1 drop), venous whole blood sample (1 K2 EDTA tube).
  • Population 1 - Individuals at risk of HIV infection (n ≥ 500) Subjects must meet have at least one risk factor for infection with HIV
  • Population 2 - Known HIV-1 positive individuals (n ≥ 500) Subjects must be a known HIV-positive individual (previous positive HIV test result)
  • Population 3 - Individuals at low risk of HIV infection (n ≥ 500) Subjects must not have any risk factors for infection with HIV

Exclusion

  • Subjects do not meet inclusion criteria

Key Trial Info

Start Date :

July 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2015

Estimated Enrollment :

1649 Patients enrolled

Trial Details

Trial ID

NCT02190578

Start Date

July 1 2014

End Date

March 1 2015

Last Update

April 24 2015

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Preventive Medicine, University of Southern California (Los Angeles)

Los Angeles, California, United States, 90007

2

Therafirst Medical Center

Fort Lauderdale, Florida, United States, 33308

3

New York City Department of Health and Mental Hygiene

Queens, New York, United States, 11101

4

Biological Specialty Corporation

Reading, Pennsylvania, United States, 19602